FDA approves Rasonque for advanced pancreatic cancer patients in the US
FDA approves Rasonque for advanced pancreatic cancer patients in the US
This is a short summary. The full story is published by Arizona Herald.
Read full story at Arizona HeraldLooking for pharma deals? Explore marketplace now Explore
FDA approves Rasonque for advanced pancreatic cancer patients in the US
This is a short summary. The full story is published by Arizona Herald.
Read full story at Arizona Herald
UNLOXCYT was approved by the US Food and Drug Administration (FDA) in 2024 for adults with metastatic or locally advanced cutaneous squamous cell…
Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to…
Awiqli® offers children 10 years and older a once-weekly basal insulin alternative, reducing basal injection frequency from seven times per week to…

Now with a new route of induction administration, subcutaneous SKYRIZI supports early symptomatic and endoscopic control with an on-body injector…
Get your company in front of buyers, manufacturers, and sourcing professionals on PharmaJungle - completely free for your first 30 days.
Exclusive introductory offer for new advertisers
Get offers from suppliers
Your product details and requirements may be published on the marketplace.
Fields marked with * are mandatory.